Delivery Order SPE2DB20D3505-SPE2DB26FYCCR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $129,776.48 to AmerisourceBergen Drug Corp for the supply of 60-tablet packages of Eliquis 5 mg tablets under a firm fixed-price contract. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a non-competitive delivery order without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of October 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,310.21 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of September 19, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,065.95 for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order from...
- The Defense Logistics Agency awarded a delivery order valued at approximately $30,042 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) under a firm fixed-price contract. The award was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and represents a non-competitive, competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and...
- The Defense Logistics Agency awarded a delivery order valued at $7,476.65 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product used in anticoagulation therapy. This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,733.67 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on October 27, 2025, with a completion date of October 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply requirements for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $20,323.56. This is a firm fixed price delivery order with an ultimate completion date of October 17, 2025, and represents a non-competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $4,119.68. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of October 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office operations based in Conshohocken, Pennsylvania, where the company maintains its primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $13,829.05 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The award was made on July 15, 2025, with an ultimate completion date of July 16, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location, serving as a critical pharmaceutical...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB26FYCCRDelivery Order
The Defense Logistics Agency awarded a $5,759.98 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of October 31, 2025. This competitive award, issued on October 30, 2025, utilizes firm fixed price terms and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive experience fulfilling medical supply needs across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 10/30/25 |